Catheter Precision Inc (VTAK) FinancialsVTAKCatheter Precision Inc

Evaluating the bottom line, Catheter Precision Inc maintains a gross margin of 90.28%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -536.57%, while the net margin is -391.20%. These profitability ratios, combined with a Return on Equity (ROE) of -185.06%, provide a clear picture of how effectively VTAK converts its operational activities into shareholder value.

In the context of the broader market, VTAK competes directly with industry leaders such as FEED and BJDX. With a market capitalization of $1.01M, it holds a significant position in the sector. When comparing efficiency, VTAK's gross margin of 90.28% stands against FEED's -111.30% and BJDX's N/A. Such benchmarking helps identify whether Catheter Precision Inc is trading at a premium or discount relative to its financial performance.

VTAK has reported increasing revenues, with $432,000 in Q1 2026, but continues to face significant net losses, including a net income loss of $3.04 million in the same quarter. The gross margin remains strong at 90.28%, but the overall financial outlook is overshadowed by persistent losses.